Table 1.
Survey places | EuroQol version | Self-rating of EQ-5D profile and EQ-VAS | Valuation data | No. of health states in the TTO | Background variablesa | Year of survey | No. of respondents | Exclusion criteria for the valuation study | No. of respondents in the valuation data setb | Softwarec | Health state valuation method |
---|---|---|---|---|---|---|---|---|---|---|---|
Japan | EQ-5D-3L | Availabled | Available | 17 | Available | 1998 | 621 | Respondents completely missing TTO data; valued 1 or 2 states only; giving all states the same value; valued all states worse than dead | 543 | STATA | Conventional TTO |
UK | EQ-5D-3L | Available | Available | 42 | Available | 1993 | 3395 | Missing in valuation data | 2997 | LIMDEP | Conventional TTO |
Japan | EQ-5D-5L | Available | Available | 86 | Available | 2014 | 1098 | Three of the investigators (involving 72 respondents) did not follow the survey manual procedures | 1026 | STATA, SAS, and R | Lead time TTO |
England | EQ-5D-5L | Available | Available | 86 | Available | 2012–2013 | 996 | Respondents who gave the same TTO value for all health states; giving health state 55555 a value no lower than the value for the mildest health state in their block | 912 | R and WinBugs | Lead time TTO and DCE |
Spain | EQ-5D-5L | Available | N/A | 86 | Available | 2012 | 1000 | N/A | N/A | N/A | N/A |
N/A not available, TTO time trade-off, DCE discrete choice experiments
aThe background variables include age, gender, experience with serious illness by respondents themselves, their families, and others
bRepresents the number of respondents after applying the exclusion criteria. For the Japanese EQ-5D-3L dataset, this study only has access to the sample that is included in the valuation study (N = 543)
cThe software used for the original analysis in the valuation studies
d‘Available’ and ‘N/A’ refer to the availability of data for this study